FMP

FMP

Enter

CASI - CASI Pharmaceuticals...

Financial Summary of CASI Pharmaceuticals, Inc.(CASI), CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics an

photo-url-https://financialmodelingprep.com/image-stock/CASI.png

CASI Pharmaceuticals, Inc.

CASI

NASDAQ

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Phase I/IIa trial in combination with MabThera (rituximab) in patients with relapsed/refractory NHL; and CB-5339, which is in Phase I clinical trial for acute myeloid leukemia and myelodysplastic syndrome. Its product pipeline also comprises CID-103 for the treatment of patients with multiple myeloma; Thiotepa, which has multiple indications including use as a conditioning treatment for various allogeneic haemopoietic stem cell transplants; and Octreotide long acting injectable formulations for the treatment of acromegaly and for the control of symptoms associated with various neuroendocrine tumors. The company has licensing agreements with Juventas Cell Therapy Ltd; BioInvent International AB; Black Belt Therapeutics Limited; and Cleave Therapeutics, Inc. It also has distribution agreements with China Resources Pharmaceutical Commercial Group International Trading Co., Ltd; Pharmathen Global BV; and Riemser Pharma GmbH. The company was formerly known as EntreMed, Inc. and changed its name to CASI Pharmaceuticals, Inc. in June 2014. CASI Pharmaceuticals, Inc. was incorporated in 1991 and is based in Rockville, Maryland.

3.23 USD

-0.05 (-1.55%)

About

ceo

Dr. Wei-Wu He Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://www.casipharmaceuticals.com

exchange

NASDAQ

Description

CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-cell non-Hodgkin lymphoma (B-NHL); BI-1206 that is in Phase I/II trial in combination with anti-PD1 therapy Keytruda for solid tumors, and in a Pha...

CIK

0000895051

ISIN

US14757U2087

CUSIP

14757U208

Address

9620 Medical Center Drive

Phone

240 864 2600

Country

US

Employee

176

IPO Date

Jun 12, 1996

Summary

CIK

0000895051

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

14757U208

ISIN

US14757U2087

Country

US

Price

3.23

Beta

0.43

Volume Avg.

201.68k

Market Cap

43.29M

Shares

-

52-Week

1.85-8.48

DCF

2.22

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.6

P/B

-

Website

https://www.casipharmaceuticals.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest CASI News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep